Medical Facilities (TSE:DR) Reaches New 52-Week Low - Time to Sell?

Key Points

• Medical Facilities Co. shares hit a new 52-week low at C$13.99 on Thursday, closing at C$14.02.
• Despite the drop, the company announced a quarterly dividend of $0.09 per share, reflecting an annualized yield of 2.6%.
• Medical Facilities operates a diverse portfolio of surgical facilities, including four specialty hospitals and six ambulatory surgery centers in the U.S.

Medical Facilities Co. (TSE:DR - )'s share price reached a new 52-week low on Thursday . The stock traded as low as C$13.99 and last traded at C$14.02, with a volume of 31780 shares trading hands. The stock had previously closed at C$14.18.

Medical Facilities Stock Down 0.7%

The company has a market cap of C$265.52 million, a P/E ratio of 4.14, a P/E/G ratio of 3.81 and a beta of 0.01. The company has a quick ratio of 1.51, a current ratio of 1.15 and a debt-to-equity ratio of 126.06. The business's 50 day moving average is C$14.55 and its 200 day moving average is C$15.16.

Medical Facilities Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Tuesday, September 30th will be paid a $0.09 dividend. This represents a $0.36 dividend on an annualized basis and a yield of 2.6%. Medical Facilities's dividend payout ratio (DPR) is 7.59%.

Medical Facilities Company Profile

Medical Facilities Corp owns a diverse portfolio of surgical facilities in the United States. Through its wholly-owned subsidiaries, the company owns controlling interests in four specialty hospitals and six ambulatory surgery centers. The hospitals offer a range of non-emergency surgical, imaging, diagnostic and pain management procedures, and other ancillary services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.